On June 2nd, a group of plaintiffs filed a lawsuit against the makers of two popular diabetes drugs, Ozempic and Mounjaro, claiming that the companies deliberately downplayed the significant side effects of the drugs. The plaintiffs allege that the manufacturers, Merck & Co. and Novo Nordisk, misrepresented the potential for serious side effects in order to increase sales of the drugs.
Ozempic and Mounjaro are used to treat Type 2 diabetes, and both have been linked to an increased risk of stroke, heart attacks, heart failure, and pancreatitis. The plaintiffs point to a study released in May 2021 which suggests that taking the drugs over time can double the risk of these serious conditions. The study also indicated that many of the adverse side effects of Ozempic and Mounjaro were listed in the manufacturers’ drug labels but downplayed to consumers.
The lawsuit, which is seeking compensatory, treble, and general damages, accuses the companies of ignoring warnings signs and failing to inform consumers about the full scope of the dangerous side effects. The plaintiffs maintain that if they had known of the risks they would not have taken the drugs and are suing for their medical costs, pain and suffering, lost wages, and other damages.
The case is being closely watched due to the seriousness of the allegations and potential liability of the companies. If the allegations are proven true, it could set a dangerous precedent that may cause other drug makers to become more lax with their safety warnings.
The lawsuit serves as a reminder that even medications that are approved by the FDA can still present a number of risks to consumers. It is important to research any drugs you are taking in order to make an informed decision and to talk to your doctor if you have any concerns or questions.
